This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Ratings

10 Best Healthcare & Biotech ETFs for 2015

Top-Rated ETFs

Top Healthcare/Biotech ETFs as of 10/31/15

Fund NameGet InfoOverall RatingRisk Grade
iShares US Healthcare Providers ETFIHFA+B
Health Care Select Sector SPDRXLVA+B-
iShares Global HealthcareIXJA+B
Vanguard HealthCare Index ETFVHTAB-
iShares US Healthcare ETFIYHAB-
First Trust Health Care AlphaDEXFXHAB-
iShares US Medical Devices ETFIHIAC+
First Trust AMEX BiotechnologyFBTA-C+
SPDR SP Intl Health Care ETFIRYA-B-
iShares Nasdaq BiotechnologyIBBB+C+

Source: TSC Ratings

Access our ETF Research Center

TheStreet Ratings' model ranks the risk-adjusted returns on all ETFs on a monthly basis.

The 10 healthcare and biotech ETFs (listed above) are ranked highest by TheStreet Ratings' methodology.

Best ETFs for 2015

ETF Investing Center

Healthcare & Biotech ETFs

The CNBC 'Fast Money' traders took a look at the big decline in health care stocks, as well as Nike and Yahoo!.
11/20/15 5:00AM
Cramer says investors shouldn't panic when rates rise.
11/9/15 8:10PM
In part one, Cramer looked at what we can learn from the market's obvious darlings. Here's what he discerns based on mixed, the bad and the ugly.
10/27/15 6:20AM
Catch up on Jim Cramer's ideas from this past week as he discusses the unprecedented power of the short sellers to determine pricing today -- even when they bet wrong.
10/23/15 9:00PM
The selloff in specialty pharmaceutical stocks has found a new "irrational low," following Wednesday's attack on Valeant Pharmaceuticals, according to RBC Capital Markets.
10/22/15 10:46AM
Stocks are lower by mid-afternoon Tuesday, pulled down by weakness in the tech and health care sectors.
10/20/15 2:37PM
The health care information and solutions market continues to see transactions at robust multiples. M&A momentum should carry through next year, said Tom O'Connor, managing director at Berkery Noyes.
10/20/15 2:01PM
The stock markets in the United States gained today. Investors are getting a breather as equities managed to recover some losses from its worst quarterly decline since 2011. Sign up for our free newsl...
9/30/15 5:12PM
The trading panel discussed Tesla's Model X, the drop in biotech stocks and if Apple's iPhones will really make a difference.
9/30/15 5:00AM
The CNBC 'Fast Money' traders take a look at U.S. stocks, as China's PMI data comes in weak once again.
9/23/15 3:06PM

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Real Money
Try it NOW

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%
Top Rated Stocks Top Rated Funds Top Rated ETFs